In DCIS.com cells, CCL2 and HGF co-treatment enhanced phosphorylation of AKT, AMPK, p42/44MAPK and PKC more than CCL2 or HGF alone. The gene discussed is HGF; the disease is ductal breast carcinoma in situ.